BIOCEPT INC Quarterly Debt-to-equity in % from Q3 2014 to Q2 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Biocept Inc quarterly Debt-to-equity history and growth rate from Q3 2014 to Q2 2023.
  • Biocept Inc Debt-to-equity for the quarter ending June 30, 2023 was 296 %, a 333% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2023 296 +228 +333% Jun 30, 2023
Q1 2023 161 +96.4 +150% Mar 31, 2023
Q4 2022 105 +36.5 +53.4% Dec 31, 2022
Q3 2022 80.7 +3.73 +4.85% Sep 30, 2022
Q2 2022 68.3 -10.7 -13.6% Jun 30, 2022
Q1 2022 64.4 -2.65 -3.95% Mar 31, 2022
Q4 2021 68.4 +15.9 +30.4% Dec 31, 2021
Q3 2021 77 +37.7 +95.8% Sep 30, 2021
Q2 2021 79.1 +38.7 +95.7% Jun 30, 2021
Q1 2021 67.1 +17.3 +34.8% Mar 31, 2021
Q4 2020 52.5 -8.46 -13.9% Dec 31, 2020
Q3 2020 39.3 -32.5 -45.3% Sep 30, 2020
Q2 2020 40.4 -26.1 -39.3% Jun 30, 2020
Q1 2020 49.8 -37.8 -43.1% Mar 31, 2020
Q4 2019 60.9 -40.4 -39.9% Dec 31, 2019
Q3 2019 71.9 -39.6 -35.5% Sep 30, 2019
Q2 2019 66.5 -87.4 -56.8% Jun 30, 2019
Q1 2019 87.5 -38.7 -30.7% Mar 31, 2019
Q4 2018 101 -20 -16.5% Dec 31, 2018
Q3 2018 111 -17.1 -13.3% Sep 30, 2018
Q2 2018 154 -59.5 -27.9% Jun 30, 2018
Q1 2018 126 -349 -73.4% Mar 31, 2018
Q4 2017 121 +720 Dec 31, 2017
Q3 2017 128 +1.75K Sep 30, 2017
Q2 2017 213 -76.5 -26.4% Jun 30, 2017
Q1 2017 475 +340 +251% Mar 31, 2017
Q4 2016 -598 -680 -834% Dec 31, 2016
Q3 2016 -1.62K -1.71K -1874% Sep 30, 2016
Q2 2016 290 +189 +188% Jun 30, 2016
Q1 2016 135 +20.3 +17.6% Mar 31, 2016
Q4 2015 81.5 -31 -27.5% Dec 31, 2015
Q3 2015 91.4 -315 -77.5% Sep 30, 2015
Q2 2015 101 Jun 30, 2015
Q1 2015 115 Mar 31, 2015
Q4 2014 113 Dec 31, 2014
Q3 2014 406 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.